| 产品编号 | bs-19022R |
| 英文名称 | NARG1L |
| 中文名称 | NMDA受体调节1样蛋白抗体 |
| 别 名 | DKFZp686O08147; MGC40612; N alpha acetyltransferase 16, NatA auxiliary subunit; N(alpha) acetyltransferase 16, NatA auxiliary subunit; NARG1 like protein; NAT2; NMDA receptor regulated 1 like; NMDA receptor regulated 1 like protein; OTTHUMP00000018318; OTTHUMP00000018320; OTTHUMP00000198977; RP11-396A22.1. |
| 研究领域 | 细胞生物 免疫学 |
| 抗体来源 | Rabbit |
| 克隆类型 | Polyclonal |
| 交叉反应 | (predicted: Human,Mouse,Rat,Chicken,Dog,Pig,Cow,Horse,Rabbit) |
| 产品应用 | IHC-P=1:100-500, IHC-F=1:100-500, ICC=1:100-500, IF=1:100-500
not yet tested in other applications. optimal dilutions/concentrations should be determined by the end user. |
| 理论分子量 | 101kDa |
| 细胞定位 | 细胞浆 |
| 性 状 | Liquid |
| 浓 度 | 1mg/ml |
| 免 疫 原 | KLH conjugated synthetic peptide derived from human NARG1L: 551-650/864 |
| 亚 型 | IgG |
| 纯化方法 | affinity purified by Protein A |
| 缓 冲 液 | 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
| 保存条件 | Shipped at 4℃. Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. |
| 注意事项 | This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. |
| PubMed | PubMed |
| 产品介绍 |
The NARG1-like protein (NARG1L) is an 864 amino acid protein that contains 7 TPR repeats and may also be a component of a complex that displays N-terminal acetyltransferase activity. Function: Auxillary subunit of the N-terminal acetyltransferase A (NatA) complex which displays alpha (N-terminal) acetyltransferase activity. Subunit: Component of the N-terminal acetyltransferase A (NatA) complex composed of NAA10 and NAA16. Similarity: Contains 7 TPR repeats. SWISS: Q6N069 Gene ID: 79612 Database links: Entrez Gene: 79612 Human Entrez Gene: 66897 Mouse SwissProt: B0QZ59 Human SwissProt: Q6N069 Human SwissProt: Q9DBB4 Mouse |
| 1、抗体溶解方法 | |
| 2、抗体修复方式 | |
| 3、常用试剂的配制 | |
| 4、免疫组化操作步骤 | |
| 5、免疫组化问题解答 | |
| 6、Western Blotting 操作步骤 | |
| 7、Western Blotting 问题解答 | |
| 8、关于肽链的设计 | |
| 9、多肽的溶解与保存 | |
| 10、酶标抗体效价测定程序 | |
